TIL-ACT therapy starts with isolating the natural infiltrating lymphocytes from the tumor tissues, expanding them in vitro, and then infusing these cells back with a high dose of IL-2 to ensure anti-tumor efficacy. Here, IL2 is linked to neoplasm.